Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037734 | SCV000061396 | uncertain significance | not specified | 2012-04-13 | criteria provided, single submitter | clinical testing | The 1525-7G>A variant in TGFBR2 has not been previously reported in the literatu re or identified by our laboratory. This variant is located in the 3' splice re gion and computational tools do not predict altered splicing. However, this inf ormation is not predictive enough to rule out pathogenicity. It has also been i dentified in 3/7020 European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). Although t his data supports that the 1525-7G>A variant may be benign, additional studies a re needed to fully assess its clinical significance. |
Gene |
RCV000037734 | SCV000168944 | benign | not specified | 2013-02-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000541600 | SCV000658824 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000541600 | SCV000782371 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000541600 | SCV000903670 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-04-13 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277126 | SCV002566154 | likely benign | Ehlers-Danlos syndrome | 2020-06-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003934914 | SCV004749519 | likely benign | TGFBR2-related disorder | 2019-03-06 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV000858806 | SCV001808440 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000858806 | SCV001967075 | likely benign | not provided | no assertion criteria provided | clinical testing |